Company: COHN
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0001437749-25-007158
Chunk: 1873

Company: Cohen & Co Inc.
Filing Date: 2025-03-12
Form: 10-K
Item: Item 2
Chunk 1873
---
 of whether the “practical expedient” provisions of ASC 820 have been applied), which are measured at fair value on a recurring basis as of  December 31, 2024 and 2023.
     
    FAIR VALUE MEASUREMENTS OF INVESTMENTS IN CERTAIN ENTITIES 
 THAT CALCULATE NET ASSET VALUE PER SHARE (OR ITS EQUIVALENT) 
 (Dollars in Thousands) 

       December 31, 2024    Unfunded Commitments    Redemption Frequency    Redemption Notice Period  
 Other investments, at fair value                 
 CREO JV (a)  $6,432  $10,118    N/A     N/A  
 U.S. Insurance JV (b)   2,825   N/A    N/A     N/A  
  $9,257             

       December 31, 2023    Unfunded Commitments    Redemption Frequency    Redemption Notice Period  
 Other investments, at fair value                 
 CREO JV (a)  $4,783  $11,150   N/A   N/A 
 U.S. Insurance JV (b)   3,107   N/A   N/A   N/A 
  $7,890             

   N/A – Not applicable.
   ﻿ 
   (a)The CREO JV invests in primarily multi-family commercial real estate mortgage-backed loans.
 (b)  The U.S. Insurance JV invests in USD denominated debt issued by small and medium sized insurance and reinsurance companies. 

        F-
       32

   10. DERIVATIVE FINANCIAL INSTRUMENTS 
   ﻿ 
   The Company  may, from time to time, enter into the following derivative instruments:
    
   Equity Derivatives
    
   A significant portion of the Company’s equity holdings are carried at fair value.  From time to time, the Company hedges a portion of this exposure by entering into equity derivatives such as puts and short call options.  These derivative positions are held at fair value as a component of other investments, at fair value and other investments sold, not yet purchased in the Company’s consolidated balance sheets.  As of  December 31, 2024 and  December 31, 2023, the Company had no